C16 Peptide Promotes Vascular Growth and Reduces Inflammation in a Neuromyelitis Optica Model
The goal of this study was to elucidate the mechanism of action of C16, a laminin-1 peptide that competes with αvβ3 for integrin binding, in treating neuromyelitis optica (NMO). A NMO rat model was established and specific inhibitors were used to investigate the effect of Tie2 kinase, integrin, and...
Main Authors: | Haohao Chen, Xiaoxiao Fu, Jinzhan Jiang, Shu Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01373/full |
Similar Items
-
Pediatric Neuromyelitis Optica Spectrum Disorders: Three Case Reports and Review of Literature
by: Seyed Mohammad Baghbanian, et al.
Published: (2020-04-01) -
Multisystem involvement in neuromyelitis optica
by: Megan M Langille, et al.
Published: (2015-01-01) -
Plasmapheresis for Neuromyelitis Optica: A Review from the Transfusion Medicine Specialist’s Perspective
by: Akshay Batra, et al.
Published: (2018-08-01) -
NMO-DBr: the Brazilian Neuromyelitis Optica Database System
by: Marco A. Lana-Peixoto, et al.
Published: (2011-08-01) -
Neuromyelitis Optica: An Often Forgotten Cause of Intractable Nausea and Vomiting
by: Chijioke Enweluzo, et al.
Published: (2013-07-01)